1. Germany Stocks

  2. •

    Health services

  3. •

    Hospital/Nursing management
MEDICLIN Aktiengesellschaft

MEDICLIN Aktiengesellschaft

5.25
EUR
+0.10
(+1.94%)
0.61EPS
6.43P/E
185.25MMarket Cap
Nov 05Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
10.84
11.33
11.69
12.22
12.82
13.58
14.17
13.89
14.17
14.84
15.37
15.76
16.52
16.39
Basic EPS, GAAP
-0.06
0.18
0.35
0.35
0.08
0.16
0.2
-0.19
0.03
0.2
-0.23
0.52
0.54
0.61
Free Cash Flow per Basic Share
-0.14
0.26
0.1
0.08
-0.33
-0.39
0.52
1.96
1.37
0.18
0.85
0.76
1.07
1.08
Dividend per Share
- -
- -
- -
- -
- -
0.05
0.05
- -
- -
- -
- -
- -
0.04
- -
Book Value per Share
3.21
3.25
3.57
3.83
3.91
4.03
4.02
3.73
3.86
4.4
4.12
4.68
5.24
5.46
Tangible Book Value per Share
2.12
2.19
2.51
2.73
2.75
2.84
2.8
2.51
2.66
3.24
3.64
4.16
4.88
5.1
Basic Weighted Avg Shares
48
48
48
48
48
48
48
48
48
48
48
48
48
48
Sales/Revenue/Turnover
515
538
555
580
609
645
673
660
673
705
730
749
785
787
Operating Margin (%)
0.27
2.73
4.08
3.98
0.94
2.19
3.18
-0.11
1.62
2.61
1.6
6.73
6.69
9.02
Depreciation Expense
17
19
18
19
20
22
71
77
74
71
86
50
60
61
Net Income, GAAP
-3
9
17
17
4
8
10
-9
1
9
-11
25
25
29
Effective Tax Rate (%)
- -
28.44
17.04
20.57
6.95
34.54
16.6
- -
39.28
0.59
- -
22.44
26.41
27.74
Profit Margin (%)
-0.51
1.58
2.98
2.85
0.64
1.2
1.44
-1.36
0.22
1.34
-1.48
3.32
3.25
3.7
Working Capital
41
49
56
69
64
61
20
33
53
91
154
132
115
131
LT Debt
61
54
47
46
37
55
441
406
358
452
454
436
362
340
Total Equity
152
154
169
182
185
191
191
177
183
209
196
223
250
260
Return on Invested Capital (%)
- -
5.19
8.92
8.21
2.57
3.9
3.85
- -
1.09
2.9
- -
6.03
6.02
7.7
Return on Capital (%)
- -
5.26
8.92
8.27
2.62
3.92
3.87
- -
1.1
2.95
- -
6.37
6.22
6.65
Return on Common Equity (%)
-1.7
5.54
10.21
9.42
2.13
4.09
5.05
-4.89
0.81
4.81
-5.32
11.87
10.81
11.85

Capital Structure

EUR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
28
28
28
LT Borrowings
14
- -
- -
LT Finance Leases
349
342
340
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
48
48
48
Market Capitalization
163
162
185

Working Capital

EUR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
284
291
300
Cash, Cash Equivalents & STI
82
152
159
Accounts Receivable, Net
86
88
92
Inventories
5
6
5
Total Current Liabilities
169
167
169
Payables & Accruals
- -
- -
- -
ST Debt
28
28
28
Deferred Revenue
- -
- -
- -

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
4.23%
7.44%
12.07%
Free Cash Flow
-19.87%
56.61%
42.2%
Net Income, GAAP
-25.91%
-22.46%
2.6%
Sales/Revenue/Turnover
3.54%
3.52%
4.77%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

EUR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
185
183
190
191
749
2025
177
191
203
198
785
2026
187
199
- -
- -
- -

Quarterly Earnings Per Share

EUR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.03
0.04
0.3
0.21
0.52
2025
- -
0.2
0.32
0.01
0.54
2026
0.07
0.21
- -
- -
- -

Quarterly Dividends Per Share

EUR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
0.04
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Tino Fritz
Full Time Employees
9,996
Sector
Health services
Industry
Hospital/Nursing management
Address
Okenstrasse 27 Offenburg BW Germany 77652
IPO Date
Dec 4, 2000
Website
mediclin.de
Similar Companies
Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP)
Max Healthcare Institute Ltd (NSE:MAXHEALTH)
Fortis Healthcare Ltd. (NSE:FORTIS)
Bangkok Dusit Medical Services Public Co. Ltd. (SET:BDMS)
Yatharth Hospital and Trauma Care Services Limited (NSE:YATHARTH)
HCA Healthcare, Inc. (NYSE:HCA)
Business
Mediclin AG operates as a healthcare provider in Germany, specializing in professional medical services across acute care, post-acute rehabilitation, and inpatient nursing care segments. The company’s core offerings include acute medical care with a focus on neurology, neurological early rehabilitation, neurosurgery, psychosomatics, psychiatry, geriatrics, orthopedics, and internal medicine including cardiology, pneumology, and endocrinology. Additionally, Mediclin provides specialized treatments in tinnitus, cochlear implants, and addresses post- and long-COVID-19 conditions. Its services extend to outpatient and inpatient care delivered through a network of hospitals, rehabilitation clinics, nursing homes, and medical care centers across eleven federal states in Germany, operating approximately 8,200 beds and around 31 medical facilities. Founded in 1994 and headquartered in Offenburg, Germany, Mediclin also manages integrated care pathways that link acute and post-acute treatments to enhance the quality and efficiency of medical services. Recent developments include steady growth in its financial performance, achieving a 5.1% increase in consolidated group sales during the first nine months of 2025, and strategic operational moves such as the acquisition of the Robert Janker Klinik in Bonn and the renewal of lease agreements for 20 clinic locations. The company continues to focus on expanding its rehabilitation offerings and strengthening its service infrastructure while maintaining high standards in interdisciplinary medical care delivery. Mediclin’s comprehensive healthcare model targets a wide range of patient needs from acute illness treatment to long-term rehabilitation and nursing care services within the German healthcare system.